Lonza Group AG LONN

Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Gene Transfer Technologies Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.The global Gene Transfer Technologies Market is projected to witness robust growth during the forecast period from 2026 to 2036, driven by the rapid expansion of gene and cell therapies, increasing investments in genomic medicine, and continuous advancements in vector engine

Europe’s cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturingDublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Europe Automated and Closed Cell Therapy Processing Systems Market Size, Share & Industry Analysis Report by Type, Scale, Workflow, Country Outlook and Forecast, 2026-2033" has been added to ResearchAndMarkets.com's offering. The Europe automated and closed cell therapy pr

PAHC vs. LZAGY: Which Stock Is the Better Value Option?

Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient formulations provide the essential environment for growing and maintaining cells used in biopharmaceutical manufacturing, vaccine production, regenerative medicine, and advanced biomedical research.

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Digital Twin Market size & share revenue was valued at approximately USD 0.89 Billion in 2025 and is expected to reach USD 1.08 Billion in 2026 and is expected to reach around USD 6.47 Billion by 2035, at a CAGR of 19.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Siemens AG (SIMATIC Biopr

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Stem Cell Culture Media Market size & share revenue was valued at approximately USD 765 Million in 2025 and is expected to reach USD 868 Million in 2026 and is expected to reach around USD 2714 Million by 2035, at a CAGR of 13.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are PAN Biotech GmbH, Sartorius

According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion in 2026 to USD 7.1 billion by 2036, expanding at a CAGR of 6.6% during the forecast period. Market growth is being driven by rising biologics production, expanding cell and gene therapy pipelines, increasing adoption of serum-free formulations, and growing demand for reproducible, GMP-grade manufacturing inputs across regulated biopharmaceutical

Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., and Patheon Pharma Services Lead the Industry Oral Solid Dosage Contract Manufacturing Market Oral Solid Dosage Contract Manufacturing Market Dublin, April 30, 2026 (GLOBE NEWSWIRE) -- The "Oral Solid Dosage Contract Manufacturing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oral solid dosage contract manufacturing market has been experiencing significant growth, expanding fr

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cell Culture Media Bags Market size & share revenue was valued at approximately USD 1.30 Billion in 2025 and is expected to reach USD 1.37 Billion in 2026 and is expected to reach around USD 2.28 Billion by 2035, at a CAGR of 5.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are GE Healthcare, Thermo Fish

Wondering whether Lonza Group at about CHF 508 per share still makes sense for your portfolio, or if better value is available elsewhere? The stock has been fairly volatile recently, with a 4.8% decline over the last week, an 8.7% gain over the last month, and returns of 5.1% lower year to date and 8.9% lower over the last year. Recent coverage has focused on how Lonza Group fits into the wider life sciences sector and what that might mean for investor sentiment. This news context helps...

With a focus on specialty medicines, growth is driven by pharmaceutical needs for cost-effective, efficient production and regulatory compliance via CDMOs Small Molecule Innovator API CDMO Market Small Molecule Innovator API CDMO Market Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type, Customer Type, Therapeutic Area, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offe

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media Market size & share revenue was valued at approximately USD 1.9 Billion in 2025 and is expected to reach USD 2.1 Billion in 2026 and is expected to reach around USD 3.5 Billion by 2035, at a CAGR of 6.2% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien

Most readers would already be aware that Lonza Group's (VTX:LONN) stock increased significantly by 8.8% over the past...

Lonza Group AG ( VTX:LONN ) saw significant share price movement during recent months on the SWX, rising to highs of...